Related Experiment Videos
[Psychotherapy and drugs. Conquering panic]
1Angstambulanz Klinik und Poliklinik für Psychiatrie und Psychotherapie-Innenstadt-München.
MMW Fortschritte Der Medizin
|June 20, 2002
Summary
Panic disorder affects 3.5% of people and often requires effective treatment. Selective serotonin reuptake inhibitors (SSRIs) offer a 60% remission rate for uncomplicated cases within weeks.
Area of Science:
- Psychiatry
- Clinical Psychology
Background:
- Panic disorder is a significant psychiatric condition with a 3.5% lifetime prevalence.
- It frequently presents with comorbidities and a chronic course, often leading to inadequate diagnosis and insufficient treatment.
- Current therapeutic strategies require enhancement to improve patient outcomes.
Purpose of the Study:
- To evaluate the efficacy of Selective Serotonin Reuptuptake Inhibitors (SSRIs) as a therapeutic option for panic disorder.
- To assess the remission rates and time course of treatment response in patients with uncomplicated panic disorder.
Main Methods:
- Review of existing literature on panic disorder treatment.
- Analysis of remission rates associated with SSRI therapy.
- Comparison of SSRI efficacy against other common therapeutic strategies.
Main Results:
- Selective Serotonin Reuptuptake Inhibitors (SSRIs) demonstrate a 60% remission rate in patients with uncomplicated panic disorder.
- Remission is typically achieved within a few weeks of initiating SSRI treatment.
- Behavioral therapy is also a recognized treatment, but SSRIs show significant efficacy.
Conclusions:
- SSRI therapy is an effective treatment for uncomplicated panic disorder, offering rapid remission.
- The findings highlight the importance of considering SSRIs in the treatment protocols for panic disorder.
- Further research may explore optimizing SSRI use in complex or comorbid cases.